Literature DB >> 11209953

First evidence of a delay-dependent working memory-enhancing effect of modafinil in mice.

D Béracochéa1, B Cagnard, A Célérier, J le Merrer, M Pérès, C Piérard.   

Abstract

This study investigated the effects of pretest injection of modafinil on delayed spontaneous alternation rates (SA) used to evaluate working memory in C57 Bl/6 mice. In a first experiment, systemic modafinil at 64 mg/kg, but not at 8 mg/kg or 32 mg/kg doses produced a significant increase of alternation scores (intertrial interval (ITI) 60s) when compared with controls. In a second experiment, modafinil (64 mg/kg) enhanced the alternation rates mainly at long (60 s and 180 s) but not at short (5 s) ITIs. Exploratory latencies and activity in a four hole-board apparatus were not modified by modafinil administration. These experiments are the first to demonstrate a delay-dependent working memory-enhancing effect of modafinil.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11209953     DOI: 10.1097/00001756-200102120-00038

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  23 in total

1.  Stress modulation of the memory retrograde-enhancing effects of the awakening drug modafinil in mice.

Authors:  Daniel Béracochéa; Pierrette Liscia; Christophe Tronche; Frédéric Chauveau; Jean-Claude Jouanin; Christophe Piérard
Journal:  Psychopharmacology (Berl)       Date:  2007-10-13       Impact factor: 4.530

2.  Modafinil Activates Phasic Dopamine Signaling in Dorsal and Ventral Striata.

Authors:  Martin J Bobak; Matthew W Weber; Melissa A Doellman; Douglas R Schuweiler; Jeana M Athens; Steven A Juliano; Paul A Garris
Journal:  J Pharmacol Exp Ther       Date:  2016-10-12       Impact factor: 4.030

3.  Modafinil prevents inhibitory avoidance memory deficit induced by sleep deprivation in rats.

Authors:  Karin Monteiro Moreira; Tatiana Lima Ferreira; Debora Cristina Hipolide; Raquel Vecchio Fornari; Sergio Tufik; Maria Gabriela Menezes Oliveira
Journal:  Sleep       Date:  2010-07       Impact factor: 5.849

4.  Modulation of fronto-cortical activity by modafinil: a functional imaging and fos study in the rat.

Authors:  Alessandro Gozzi; Valeria Colavito; Paul F Seke Etet; Dino Montanari; Silvia Fiorini; Stefano Tambalo; Angelo Bifone; Gigliola Grassi Zucconi; Marina Bentivoglio
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

Review 5.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: implications for addiction.

Authors:  Tristan Shuman; Denise J Cai; Jennifer R Sage; Stephan G Anagnostaras
Journal:  Behav Brain Res       Date:  2012-08-03       Impact factor: 3.332

7.  Anti-narcoleptic agent modafinil and its sulfone: a novel facile synthesis and potential anti-epileptic activity.

Authors:  Nithiananda Chatterjie; James P Stables; Hsin Wang; George J Alexander
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

8.  Impact of Astroglial Connexins on Modafinil Pharmacological Properties.

Authors:  Adeline Duchêne; Magali Perier; Yan Zhao; Xinhe Liu; Julien Thomasson; Frédéric Chauveau; Christophe Piérard; Didier Lagarde; Christèle Picoli; Tiffany Jeanson; Franck Mouthon; Yves Dauvilliers; Christian Giaume; Jian-Sheng Lin; Mathieu Charvériat
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

Review 9.  Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.

Authors:  José A Apud; Daniel R Weinberger
Journal:  NeuroRx       Date:  2006-01

10.  Effects of modafinil on working memory processes in humans.

Authors:  Ulrich Müller; Nikolai Steffenhagen; Ralf Regenthal; Peter Bublak
Journal:  Psychopharmacology (Berl)       Date:  2004-06-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.